Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jan;17(1):208-17.
doi: 10.1128/CMR.17.1.208-217.2004.

Strongyloides stercoralis in the Immunocompromised Population

Affiliations
Review

Strongyloides stercoralis in the Immunocompromised Population

Paul B Keiser et al. Clin Microbiol Rev. 2004 Jan.

Abstract

Strongyloides stercoralis is an intestinal nematode of humans that infects tens of millions of people worldwide. S. stercoralis is unique among intestinal nematodes in its ability to complete its life cycle within the host through an asexual autoinfective cycle, allowing the infection to persist in the host indefinitely. Under some conditions associated with immunocompromise, this autoinfective cycle can become amplified into a potentially fatal hyperinfection syndrome, characterized by increased numbers of infective filariform larvae in stool and sputum and clinical manifestations of the increased parasite burden and migration, such as gastrointestinal bleeding and respiratory distress. S. stercoralis hyperinfection is often accompanied by sepsis or meningitis with enteric organisms. Glucocorticoid treatment and human T-lymphotropic virus type 1 infection are the two conditions most specifically associated with triggering hyperinfection, but cases have been reported in association with hematologic malignancy, malnutrition, and AIDS. Anthelmintic agents such as ivermectin have been used successfully in treating the hyperinfection syndrome as well as for primary and secondary prevention of hyperinfection in patients whose exposure history and underlying condition put them at increased risk.

PubMed Disclaimer

References

    1. Adam, M., O. Morgan, C. Persaud, and W. N. Gibbs. 1973. Hyperinfection syndrome with Strongyloides stercoralis in malignant lymphoma. Br. Med. J. 1:264-266. - PMC - PubMed
    1. Archibald, L. K., N. J. Beeching, G. V. Gill, J. W. Bailey, and D. R. Bell. 1993. Albendazole is effective treatment for chronic strongyloidiasis. Q. J. Med. 86:191-195. - PubMed
    1. Armignacco, O., A. Capecchi, P. De Mori, and L. R. Grillo. 1989. Strongyloides stercoralis hyperinfection and the acquired immunodeficiency syndrome. Am. J. Med. 86:258. - PubMed
    1. Ashraf, M., C. L. Gue, and L. M. Baddour. 1996. Case report: strongyloidiasis refractory to treatment with ivermectin. Am. J. Med. Sci. 311:178-179. - PubMed
    1. Berk, S. L., A. Verghese, S. Alvarez, K. Hall, and B. Smith. 1987. Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch. Intern. Med. 147:1257-1261. - PubMed

LinkOut - more resources